This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Yuji Kito: Innovator in Hepatitis C Treatment
Introduction
Yuji Kito is a notable inventor based in Nagaokakyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis C. His innovative approach has led to the development of a therapeutic composition that enhances the effectiveness of existing treatments.
Latest Patents
Yuji Kito holds a patent for an "Ameliorant for hepatitis C therapeutic effect and application thereof." This invention provides a therapeutic composition that combines IFN-α and IFN-γ as active ingredients, along with a pharmaceutically acceptable carrier. The method aims to treat hepatitis C by administering both IFN-α and IFN-γ simultaneously or sequentially. This invention is particularly valuable for patients who are difficult to treat with conventional methods, as it has the potential to make patients continuously HCV-RNA negative.
Career Highlights
Kito is associated with Otsuka Pharmaceutical Company, Limited, where he continues to work on innovative solutions for chronic diseases. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Yuji Kito has collaborated with notable colleagues, including Aya Furukawa and Norio Hayashi. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Yuji Kito's work in enhancing hepatitis C treatment demonstrates his commitment to improving patient outcomes through innovation. His contributions to the field are invaluable and highlight the importance of continued research in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
